SB 202190 hydrochloride is a selective and cell-permeable p38 MAPK inhibitor that inhibits p38alpha and p38beta2 (IC50=50/100 nM). SB 202190 hydrochloride has anti-tumor activity and can also induce the differentiation of human embryonic stem cells into cardiomyocytes.